Silence Therapeutics PLC (SLN) — Cash Flow Reinvestment Rate
Silence Therapeutics PLC (SLN) has a Cash Flow Reinvestment Rate of 0.02x as of June 2021, reinvesting $440.00K (capex $439.00K plus investments $1.00K) from operating cash flow of $26.03 Million. Check Silence Therapeutics PLC cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Silence Therapeutics PLC Cash Flow Reinvestment Rate (2019–2021)
Historical reinvestment intensity for Silence Therapeutics PLC across 2 annual periods. Explore SLN long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Silence Therapeutics PLC (2019–2021)
Year-by-year capital reinvestment analysis for Silence Therapeutics PLC. For live market cap and broader valuation context, see how much is Silence Therapeutics PLC worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 1.28x | $11.80 Million | $9.19 Million | $1.80 Million | ▼ -85.2% |
| 2019 | 8.70x | $15.02 Million | $1.73 Million | $9.00K | — |